Dr. Wolfgang Wienand is Chief Executive Officer of Lonza Group AG from July 1, 2024. Dr. Wienand had been Chief Executive Officer at Siegfried Holding AG since January 01, 2019 until 2024. He is Independen...

리더십 팀

이름	위치	테뉴어	보상	소유권
Wolfgang Wienand	Chief Executive Officer	less than a year	데이터 없음	데이터 없음
Philippe Deecke	Chief Financial Officer	2.8yrs	데이터 없음	0.0032% CHF 1.2m
Maria Nunez	Head of Group Operations	2.1yrs	데이터 없음	0.00019% CHF 73.4k
Dirk Oehlers	Vice President of Investor Relations	no data	데이터 없음	데이터 없음
Andreas Bohrer	Group General Counsel & Company Secretary	no data	데이터 없음	데이터 없음
Kim Harrelson	Head of Ethics & Compliance	no data	데이터 없음	데이터 없음
Victoria Morgan	Head of External Communications	no data	데이터 없음	데이터 없음
Jennifer Clancy	Senior Director of Global Marketing	6.4yrs	데이터 없음	데이터 없음
Matthias Hofmann	Head of Corporate Environment	no data	데이터 없음	데이터 없음
Jean-Christophe Hyvert	President of Biologics Division	3.7yrs	데이터 없음	0.0029% CHF 1.1m
Aurelie Dalbiez	Head of Strategic HR Projects	no data	데이터 없음	데이터 없음
Gordon Bates	President of Small Molecules Division	3.7yrs	데이터 없음	0.0033% CHF 1.3m

3.2yrs

평균 재임 기간

52yo

평균 연령

경험이 풍부한 관리: LONN 의 관리팀은 경험 ( 3.1 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Barbara Richmond	Independent Non-Executive Director	10.4yrs	CHF 316.30k	0.0058% CHF 2.2m
Christoph Mader	Lead Independent Director	8.4yrs	CHF 334.77k	0.0059% CHF 2.3m
Jurgen Steinemann	Independent Vice-Chairman	10.4yrs	CHF 239.33k	0.013% CHF 4.9m
Roger Nitsch	Independent Director	2.3yrs	CHF 251.00k	0.00051% CHF 196.9k
Marion Helmes	Independent Director	2.3yrs	CHF 239.33k	0.00051% CHF 196.9k
Angelica Kohlmann	Independent Director	6.3yrs	CHF 334.77k	0.0023% CHF 876.5k
Olivier Verscheure	Independent Director	6.3yrs	CHF 251.00k	0.0021% CHF 810.9k
Jean-Marc Huet	Independent Chairman	less than a year	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

64yo

평균 연령

경험이 풍부한 이사회: LONN 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.

Lonza Group 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

Lonza Group AG Announces Chief Executive Officer Changes

Lonza Group AG, Annual General Meeting, May 08, 2024

Lonza Group AG Announces CEO Changes

Lonza Group AG, Annual General Meeting, May 05, 2023

Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division, Effective from November 1, 2022

Lonza Group Announces Management Changes, Effective August 1, 2022

Recent updates

Lonza Group AG (VTX:LONN) Not Flying Under The Radar

First half 2024 earnings: EPS in line with analyst expectations despite revenue beat

Now 20% overvalued after recent price rise

Lonza Group AG to Report Fiscal Year 2024 Results on Jan 30, 2025

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Lonza Group AG's (VTX:LONN) Share Price Matching Investor Opinion

Lonza Group AG Approves Cash Dividend, Payable on May 15, 2024

Some Investors May Be Willing To Look Past Lonza Group's (VTX:LONN) Soft Earnings

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Dividend increased to CHF4.00

Now 21% undervalued

Lonza Group AG Announces Chief Executive Officer Changes

Estimating The Intrinsic Value Of Lonza Group AG (VTX:LONN)

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Now 20% undervalued

Lonza Group AG (VTX:LONN) Looks Just Right With A 25% Price Jump

Price target increased by 7.3% to CHF503

Lonza Group AG to Report First Half, 2024 Results on Jul 25, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Lonza Group AG to Report Fiscal Year 2023 Results on Jan 26, 2024

Lonza Group AG, Annual General Meeting, May 08, 2024

Price target decreased by 8.9% to CHF463

Calculating The Intrinsic Value Of Lonza Group AG (VTX:LONN)

Is Lonza Group (VTX:LONN) A Risky Investment?

Price target decreased by 8.4% to CHF539

Price target decreased by 8.5% to CHF569

Investor sentiment deteriorates as stock falls 17%

Lonza Group AG Provides Sales Guidance for the Year 2023

Now 24% undervalued after recent price drop

Lonza Group AG Announces CEO Changes

A Look At The Fair Value Of Lonza Group AG (VTX:LONN)

Consensus EPS estimates fall by 12%

Lonza Group AG Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

New minor risk - Share price stability

First half 2023 earnings: EPS and revenues miss analyst expectations

Lonza Group (VTX:LONN) Has A Pretty Healthy Balance Sheet

Lonza Group AG (SWX:LONN) acquired Synaffix BV.

Lonza Group AG (SWX:LONN) acquired Synaffix BV.

With EPS Growth And More, Lonza Group (VTX:LONN) Makes An Interesting Case

Lonza Group AG Reiterates Sales Guidance for the Years 2023

Upcoming dividend of CHF3.50 per share at 0.6% yield

These 4 Measures Indicate That Lonza Group (VTX:LONN) Is Using Debt Reasonably Well

Full year 2022 earnings: EPS exceeds analyst expectations

If EPS Growth Is Important To You, Lonza Group (VTX:LONN) Presents An Opportunity

Lonza Group AG to Report First Half, 2023 Results on Jul 21, 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Lonza Group AG Provides Earnings Guidance for the Year 2023

Lonza Group AG (SWX:LONN) announces an Equity Buyback for CHF 2,000 million worth of its shares.

Lonza Group AG, Annual General Meeting, May 05, 2023

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Lonza Group (VTX:LONN) On Your Watchlist?

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division, Effective from November 1, 2022

Do Lonza Group's (VTX:LONN) Earnings Warrant Your Attention?

First half 2022 earnings released

Lonza Group AG Reconfirms Sales Guidance for the Years 2022 and 2024

Lonza Group Announces Management Changes, Effective August 1, 2022

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Upcoming dividend of CHF3.00 per share

Insufficient new directors

Sigma-Aldrich Corporation acquired Modular Automated Sampling Technology Platform of Lonza Group AG.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022

Insufficient new directors

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Lonza and Triumvira Immunologics Announces First Patient with HER2-overexpressing Cancer Dosed with TAC-T Cell Therapy Using the Lonza Cocoon Platform

Lonza Group (VTX:LONN) Has A Somewhat Strained Balance Sheet

Lonza Group Ltd Provides Earnings Guidance for the Year 2021

First half 2021 earnings released: EPS CHF3.51 (vs CHF5.94 in 1H 2020)